ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

Behavior Scientists To Discuss Cancer Patient Rehabilitation

January 17, 1975

In Brief: Hammer Okay, Panel’s Pittsburgh Meeting Rescheduled For Oc 23; Campbell Leaves AICR

July 17, 1987

In Brief: New York Legislature Votes $240 Mil. Bond Issue For Roswell Park Construction; Kripke Honored

April 25, 1992

Cancer Center Planning Grants Recompetition Approved By Advisors

June 10, 1994

In Brief: Hawkins Gets Seat Back On Labor & Human Resources, Loses Subcommittee; Foundation Offers Fellowships

February 11, 1983

NIH News: Board of Governors Appointed to Oversee Clinical Center

October 24, 1996